Candida albicans Als3, a multifunctional adhesin and invasin

Eukaryotic Cell

Volumn 10, Issue 2, 2011, Pages 168-173

  Liu, Yaoping ^a   Filler, Scott G ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALS3 PROTEIN, CANDIDA ALBICANS; FUNGAL PROTEIN; FUNGUS VACCINE; IRON;

BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; STREPTOCOCCUS GORDONII;

BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; FUNGAL PROTEINS; FUNGAL VACCINES; HUMANS; IRON; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY; STREPTOCOCCUS GORDONII;

CANDIDA ALBICANS; FUNGI; STREPTOCOCCUS GORDONII;

EID: 79951490058     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00279-10     Document Type: Review

References (73)

1. Almeida, R. S., et al. 2008. The hyphal-associated adhesin and invasin Als3 of Candida albicans mediates iron acquisition from host ferritin. PLoS Pathog. 4:e1000217.
2. Almeida, R. S., D. Wilson, and B. Hube. 2009. Candida albicans iron acquisition within the host. FEMS Yeast Res. 9:1000-1012.
3. Argimon, S., et al. 2007. Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryot. Cell 6:682-692.
4. Bamford, C. V., et al. 2009. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun. 77:3696-3704.
5. Bastidas, R. J., J. Heitman, and M. E. Cardenas. 2009. The protein kinase Tor1 regulates adhesin gene expression in Candida albicans. PLoS Pathog. 5:e1000294.
6. Beucher, B., et al. 2009. Recognition of Candida albicans Als3 by the germ tube-specific monoclonal antibody 3D9.3. FEMS Immunol. Med. Microbiol. 55:314-323.
7. Brand, A., J. D. Barnes, K. S. Mackenzie, F. C. Odds, and N. A. Gow. 2008. Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol. Lett. 287:48-55.
8. Brena, S., et al. 2007. Fungicidal monoclonal antibody C7 binds to Candida albicans Als3. Infect. Immun. 75:3680-3682.
9. Butler, G., et al. 2009. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459:657-662.
10. Cawson, R. A., and K. C. Rajasingham. 1972. Ultrastructural features of the invasive phase of Candida albicans. Br. J. Dermatol. 87:435-443.
11. Chandra, J., et al. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
12. Chiang, L. Y., et al. 2007. Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis. Cell. Microbiol. 9:233-245.
13. Cleary, I. A., et al. 2010. Als3p is not required for C. albicans virulence in the mouse model of disseminated candidiasis, abstr. 30B, p. 69. Abstr. 10th ASM Conf. Candida Candidiasis.
14. Coleman, D. A., et al. 2009. Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces. J. Microbiol. Methods 78:71-78.
15. Filler, S. G., J. N. Swerdloff, C. Hobbs, and P. M. Luckett. 1995. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63:976-983.
16. Frank, A. T., et al. 2010. Structure and function of glycosylated tandem repeats from Candida albicans ALS adhesins. Eukaryot. Cell 9:405-414.
17. Garcia-Tamayo, J., G. Castillo, and A. J. Martinez. 1982. Human genital candidiasis: histochemistry, scanning and transmission electron microscopy. Acta Cytol. 26:7-14.
18. Gaur, N. K., and S. A. Klotz. 1997. Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins. Infect. Immun. 65:5289-5294.
19. Grubb, S. E., et al. 2008. Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect. Immun. 76:4370-4377.
20. Hajjeh, R. A., et al. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42:1519-1527.
21. Hogan, D. A., and R. Kolter. 2002. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:2229-2232.
22. Hoyer, L. L., and J. E. Hecht. 2001. The ALS5 gene of Candida albicans and analysis of the Als5p N-terminal domain. Yeast 18:49-60.
23. Hoyer, L. L., T. L. Payne, M. Bell, A. M. Myers, and S. Scherer. 1998. Candida albicans ALS3 and insights into the nature of the ALS gene family. Clin. Microbiol. Rev. 33:451-459.
24. Hoyer, L. L., S. Scherer, A. R. Shatzman, and G. P. Livi. 1995. Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol. Microbiol. 15:39-54.
25. Jackson, A. P., et al. 2009. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res. 19:2231-2244.
26. Kapteyn, J. C., et al. 2000. The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants. Mol. Microbiol. 35:601-611.
27. Klotz, S. A., et al. 2007. Candida albicans Als proteins mediate aggregation with bacteria and yeasts. Med. Mycol. 45:363-370.
28. Laforce-Nesbitt, S. S., M. A. Sullivan, L. L. Hoyer, and J. M. Bliss. 2008. Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p. FEMS Immunol. Med. Microbiol. 54:195-202.
29. Lin, L., et al. 2009. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 5:e1000703.
30. Lo, H. J., et al. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
31. Loza, L., et al. 2004. Functional analysis of the Candida albicans ALS1 gene product. Yeast 21:473-482.
32. Montes, L. F., and W. H. Wilborn. 1968. Ultrastructural features of hostparasite relationship in oral candidiasis. J. Bacteriol. 96:1349-1356.
33. Moragues, M. D., et al. 2003. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect. Immun. 71:5273-5279.
34. Moreno-Ruiz, E., et al. 2009. Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell. Microbiol. 11:1179-1189.
35. Nobbs, A. H., M. M. Vickerman, and H. F. Jenkinson. 2010. Heterologous expression of Candida albicans cell wall-associated adhesins in Saccharomyces cerevisiae reveals differential specificities in adherence and biofilm formation and in binding oral Streptococcus gordonii. Eukaryot. Cell 9:1622-1634.
36. Nobile, C. J., et al. 2006. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2:e63.
37. Nobile, C. J., and A. P. Mitchell. 2005. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr. Biol. 15:1150-1155.
38. Nobile, C. J., et al. 2008. Complementary adhesin function in C. albicans biofilm formation. Curr. Biol. 18:1017-1024.
39. Nobile, C. J., et al. 2008. Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell. Microbiol. 10:2180-2196.
40. Oh, S. H., et al. 2005. Functional specificity of Candida albicans Als3p proteins and clade specificity of ALS3 alleles discriminated by the number of copies of the tandem repeat sequence in the central domain. Microbiology 151:673-681.
41. Omaetxebarria, M. J., et al. 2005. Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans. Curr. Mol. Med. 5:393-401.
42. Pappas, P. G., et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
43. Park, H., et al. 2005. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell. Microbiol. 7:499-510.
44. Peters, B. M., et al. 2010. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol. Med. Microbiol. 59:493-503.
45. Phan, Q. T., P. H. Belanger, and S. G. Filler. 2000. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect. Immun. 68:3485-3490.
46. Phan, Q. T., R. A. Fratti, N. V. Prasadarao, J. E. Edwards, Jr., and S. G. Filler. 2005. N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J. Biol. Chem. 280:10455-10461.
47. Phan, Q. T., et al. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 5:e64.
48. Rajasingham, K. C., S. J. Challacombe, and S. Tovey. 1989. Ultrastructure and possible processes involved in the invasion of host epithelial cells by Candida albicans in vaginal candidosis. Cytobios 60:11-20.
49. Rauceo, J. M., et al. 2006. Threonine-rich repeats increase fibronectin binding in the Candida albicans adhesin Als5p. Eukaryot. Cell 5:1664-1673.
50. Rotrosen, D., et al. 1985. Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J. Infect. Dis. 152:1264-1274.
51. Sanchez, A. A., et al. 2004. Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect. Immun. 72:598-601.
52. Saville, S. P., A. L. Lazzell, C. Monteagudo, and J. L. Lopez-Ribot. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot. Cell 2:1053-1060.
53. Scherwitz, C. 1982. Ultrastructure of human cutaneous candidosis. J. Invest. Dermatol. 78:200-205.
54. Sevilla, M. J., B. Robledo, A. Rementeria, M. D. Moragues, and J. Ponton. 2006. A fungicidal monoclonal antibody protects against murine invasive candidiasis. Infect. Immun. 74:3042-3045.
55. Sheppard, D. C., et al. 2004. Functional and structural diversity in the Als protein family of Candida albicans. J. Biol. Chem. 279:30840-30849.
56. Silverman, R. J., A. H. Nobbs, M. M. Vickerman, M. E. Barbour, and H. F. Jenkinson. 2010. Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect. Immun. 78:4644-4652.
57. Sobel, J. D. 1986. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N. Engl. J. Med. 315: 1455-1458.
58. Spellberg, B., et al. 2008. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J. Infect. Dis. 197:967-971.
59. Spellberg, B., et al. 2008. The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect. Immun. 76:4574-4580.
60. Spellberg, B. J., et al. 2006. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis. J. Infect. Dis. 194:256-260.
61. Sun, J. N., et al. 2010. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog. 6:e1001181.
62. Torosantucci, A., et al. 2005. A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. 202:597-606.
63. Torosantucci, A., et al. 2009. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 4:e5392.
64. Tronchin, G., M. Pihet, L. M. Lopes-Bezerra, and J. P. Bouchara. 2008. Adherence mechanisms in human pathogenic fungi. Med. Mycol. 46:749-772.
65. Tsai, N. Y., S. S. Laforce-Nesbitt, R. Tucker, and J. M. Bliss. 2010. A murine model for disseminated candidiasis in neonates. Pediatr. Res. [Epub ahead of print.] doi:10.1203/PDR.0b013e318206fd3e.
66. Vazquez, J. A., et al. 2006. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin. Infect. Dis. 42:1179-1186.
67. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
68. Zakikhany, K., et al. 2007. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell. Microbiol. 9:2938-2954.
69. Zhao, X., et al. 2006. Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology 152:2287-2299.
70. Zhao, X., et al. 2004. ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. Microbiology 150:2415-2428.
71. Zhao, X., et al. 2007. Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates. Fungal Genet. Biol. 44:1298-1309.
72. Zhao, X., S. H. Oh, K. M. Yeater, and L. L. Hoyer. 2005. Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology 151:1619-1630.
73. Zhu, W., P. Boontheung, J. A. Loo, and S. G. Filler. 2010. Roles of HER2 and EGFR signaling in host cell invasion by Candida albicans, abstr. 180B, p. 127. Abstr. 10th ASM Conf. Candida Candidiasis.